95 related articles for article (PubMed ID: 8975975)
1. Multidisciplinary management of hepatocellular carcinoma.
Lygidakis NJ; Tsiliakos S
Hepatogastroenterology; 1996; 43(12):1611-9. PubMed ID: 8975975
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary management of hepatocellular carcinoma.
Lygidakis NJ; Tsiliakos S; Talaat A; Matsakis G; Tepetes K
Hepatogastroenterology; 1997; 44(13):268-73. PubMed ID: 9058157
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
[TBL] [Abstract][Full Text] [Related]
4. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
[TBL] [Abstract][Full Text] [Related]
5. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy.
Okazaki M; Yamasaki S; Ono H; Higashihara H; Koganemaru F; Kimura S; Kuroda Y; Sato S; Ryu K; Ohtsubo T
Hepatogastroenterology; 1993 Aug; 40(4):320-3. PubMed ID: 8406299
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.
Xi T; Lai EC; Min AR; Shi LH; Wu D; Xue F; Wang K; Yan Z; Xia Y; Shen F; Lau WY; Wu MC
Hepatogastroenterology; 2012 Jun; 59(116):1198-203. PubMed ID: 22580673
[TBL] [Abstract][Full Text] [Related]
7. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
[TBL] [Abstract][Full Text] [Related]
8. Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma.
Izumi R; Shimizu K; Miyazaki I
Hepatogastroenterology; 1996; 43(12):1415-20. PubMed ID: 8975941
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of liver resection with sequential transarterial chemoembolization in stage pT3 or pT4 hepatocellular carcinoma].
Hasse F; Mehring UM; Castaneda F; Jäger H; Mathias KD; Löhlein D
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():208-10. PubMed ID: 9101833
[TBL] [Abstract][Full Text] [Related]
11. Multimodality management of hepatocellular carcinoma larger than 10 cm.
Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
[TBL] [Abstract][Full Text] [Related]
12. [The results of the chemoembolization of advanced hepatocellular carcinomas. The effect on the survival times, morphological findings and tumor markers].
Wickenhöfer R; Hasan I; Schüller H; Reiser M; Hartlapp JH
Rofo; 1992 Apr; 156(4):328-32. PubMed ID: 1373966
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of chemoembolization as an adjuvant therapy for primary liver carcinoma after surgical resection].
Li JQ; Zhang YQ; Zhang WZ
Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):387-9. PubMed ID: 7895595
[TBL] [Abstract][Full Text] [Related]
14. Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem.
Lygidakis NJ; Kosmidis P; Ziras N; Parissis J; Kyparidou E
J Interferon Cytokine Res; 1995 May; 15(5):467-72. PubMed ID: 7544232
[TBL] [Abstract][Full Text] [Related]
15. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
16. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
[TBL] [Abstract][Full Text] [Related]
17. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.
Ho CM; Lee PH; Shau WY; Ho MC; Wu YM; Hu RH
Surgery; 2012 May; 151(5):700-9. PubMed ID: 22284764
[TBL] [Abstract][Full Text] [Related]
18. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
[TBL] [Abstract][Full Text] [Related]
19. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
[TBL] [Abstract][Full Text] [Related]
20. Recurrent hepatocellular carcinoma after partial hepatectomy: value of treatment with transcatheter arterial chemoembolization.
Nakoa N; Kamino K; Miura K; Hayashi T; Ohnishi M; Takayasu Y; Miura T; Okamoto E
AJR Am J Roentgenol; 1991 Jun; 156(6):1177-9. PubMed ID: 1851379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
